Asset Management Corp Crispr Therapeutics Ag Call Options Transaction History

Asset Management Corp

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Oct 21, 2022	SELL	$61.1 - $83.78 $54,990 - $75,402	-900 Reduced 20.45%	3,500 $229,000
Q1 2022 May 03, 2022	SELL	$53.19 - $79.24 $696,789 - $1.04 Million	-13,100 Reduced 74.86%	4,400 $276,000
Q4 2021 Jan 25, 2022	SELL	$70.09 - $111.29 $35,045 - $55,645	-500 Reduced 2.78%	17,500 $1.33 Million
Q3 2021 Oct 13, 2021	BUY	$110.2 - $156.64 $1.98 Million - $2.82 Million	18,000 New	18,000 $2.02 Million

490

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.18B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Asset Management Corp , based on Form 13F filings with the SEC.

Stay updated on Asset Management Corp with notifications on news.